| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Memory | 27 | 2024 | 1359 | 4.110 |
Why?
|
| Dendritic Cells | 49 | 2023 | 2725 | 3.940 |
Why?
|
| Cell Movement | 78 | 2023 | 5198 | 3.760 |
Why?
|
| Nociceptors | 6 | 2024 | 461 | 3.210 |
Why?
|
| Lymph Nodes | 58 | 2021 | 3469 | 3.080 |
Why?
|
| T-Lymphocytes | 43 | 2022 | 10188 | 1.840 |
Why?
|
| Lymphoid Tissue | 12 | 2008 | 445 | 1.660 |
Why?
|
| L-Selectin | 28 | 2008 | 209 | 1.650 |
Why?
|
| Killer Cells, Natural | 9 | 2021 | 2202 | 1.620 |
Why?
|
| T-Lymphocyte Subsets | 14 | 2022 | 1805 | 1.570 |
Why?
|
| Sensory Receptor Cells | 3 | 2023 | 512 | 1.450 |
Why?
|
| CD8-Positive T-Lymphocytes | 21 | 2022 | 4575 | 1.450 |
Why?
|
| Lymphocytes | 26 | 2017 | 2610 | 1.440 |
Why?
|
| Neutrophils | 29 | 2024 | 3764 | 1.330 |
Why?
|
| Mice | 181 | 2024 | 81402 | 1.250 |
Why?
|
| B-Lymphocytes | 24 | 2020 | 4748 | 1.250 |
Why?
|
| Models, Immunological | 13 | 2014 | 512 | 1.200 |
Why?
|
| Chemotaxis, Leukocyte | 15 | 2011 | 664 | 1.180 |
Why?
|
| Neuroimmunomodulation | 2 | 2023 | 178 | 1.180 |
Why?
|
| Cell Adhesion | 38 | 2023 | 3088 | 1.150 |
Why?
|
| Animals | 233 | 2024 | 168253 | 1.150 |
Why?
|
| Mice, Inbred C57BL | 88 | 2024 | 22121 | 1.120 |
Why?
|
| Lymphocyte Activation | 28 | 2020 | 5491 | 1.100 |
Why?
|
| Duffy Blood-Group System | 4 | 2021 | 58 | 1.050 |
Why?
|
| Venules | 26 | 2024 | 161 | 1.030 |
Why?
|
| Bone Marrow | 13 | 2022 | 2907 | 1.020 |
Why?
|
| Thymus Gland | 6 | 2021 | 1241 | 1.010 |
Why?
|
| Leukocytes | 18 | 2023 | 2024 | 1.000 |
Why?
|
| Cell Communication | 17 | 2019 | 1652 | 0.990 |
Why?
|
| Homeostasis | 9 | 2024 | 3320 | 0.980 |
Why?
|
| Receptors, Lymphocyte Homing | 11 | 2011 | 141 | 0.980 |
Why?
|
| Tretinoin | 6 | 2011 | 519 | 0.950 |
Why?
|
| Adaptive Immunity | 7 | 2024 | 725 | 0.940 |
Why?
|
| Skin | 13 | 2023 | 4474 | 0.920 |
Why?
|
| Blood | 3 | 2021 | 584 | 0.920 |
Why?
|
| Receptors, Chemokine | 12 | 2022 | 653 | 0.890 |
Why?
|
| Chemokine CCL2 | 2 | 2023 | 604 | 0.870 |
Why?
|
| Endothelium, Vascular | 22 | 2021 | 4430 | 0.860 |
Why?
|
| Immunologic Surveillance | 3 | 2016 | 92 | 0.860 |
Why?
|
| Lymphocytic choriomeningitis virus | 5 | 2020 | 178 | 0.840 |
Why?
|
| Bronchitis | 1 | 2023 | 196 | 0.830 |
Why?
|
| Blood Platelets | 11 | 2022 | 2478 | 0.830 |
Why?
|
| Endothelial Cells | 10 | 2024 | 3541 | 0.810 |
Why?
|
| Antigen Presentation | 10 | 2022 | 1254 | 0.790 |
Why?
|
| Vesiculovirus | 4 | 2013 | 55 | 0.770 |
Why?
|
| Hematopoietic Stem Cells | 12 | 2017 | 3396 | 0.750 |
Why?
|
| Macrophages | 15 | 2024 | 5764 | 0.730 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 11 | 2020 | 377 | 0.730 |
Why?
|
| T-Lymphocytes, Regulatory | 12 | 2019 | 3072 | 0.730 |
Why?
|
| Dermatitis, Allergic Contact | 2 | 2021 | 111 | 0.710 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2023 | 322 | 0.710 |
Why?
|
| Chemokines, CC | 10 | 2008 | 283 | 0.690 |
Why?
|
| Cell Adhesion Molecules | 20 | 2017 | 1600 | 0.690 |
Why?
|
| Antigens | 9 | 2014 | 1446 | 0.690 |
Why?
|
| Immunoglobulin A | 3 | 2008 | 980 | 0.690 |
Why?
|
| Integrins | 15 | 2023 | 834 | 0.680 |
Why?
|
| Herpesviridae Infections | 1 | 2021 | 270 | 0.680 |
Why?
|
| Allergy and Immunology | 1 | 2021 | 175 | 0.670 |
Why?
|
| Peripheral Nervous System | 2 | 2023 | 151 | 0.670 |
Why?
|
| P-Selectin | 15 | 2013 | 597 | 0.670 |
Why?
|
| Mice, Knockout | 51 | 2024 | 14397 | 0.660 |
Why?
|
| Adoptive Transfer | 15 | 2022 | 819 | 0.650 |
Why?
|
| Immune System | 5 | 2018 | 794 | 0.630 |
Why?
|
| Receptors, Cell Surface | 6 | 2021 | 2819 | 0.630 |
Why?
|
| Sphingosine | 6 | 2012 | 307 | 0.630 |
Why?
|
| Immunity, Mucosal | 4 | 2019 | 482 | 0.630 |
Why?
|
| Chemotaxis | 6 | 2008 | 599 | 0.620 |
Why?
|
| Bone Marrow Cells | 12 | 2022 | 2416 | 0.610 |
Why?
|
| Inflammation | 24 | 2024 | 10746 | 0.600 |
Why?
|
| Immunomodulation | 2 | 2021 | 547 | 0.580 |
Why?
|
| Chemokines | 9 | 2011 | 960 | 0.580 |
Why?
|
| Mice, Inbred BALB C | 24 | 2019 | 6206 | 0.570 |
Why?
|
| Immunity, Innate | 12 | 2021 | 3059 | 0.570 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 997 | 0.570 |
Why?
|
| Intra-Abdominal Fat | 1 | 2022 | 610 | 0.550 |
Why?
|
| Antigens, Surface | 9 | 2016 | 1608 | 0.520 |
Why?
|
| Chlamydia Infections | 2 | 2020 | 365 | 0.520 |
Why?
|
| Intestinal Mucosa | 7 | 2014 | 3026 | 0.520 |
Why?
|
| Propylene Glycols | 2 | 2006 | 91 | 0.510 |
Why?
|
| Transendothelial and Transepithelial Migration | 5 | 2024 | 100 | 0.510 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 1010 | 0.500 |
Why?
|
| Cell Differentiation | 15 | 2021 | 11526 | 0.500 |
Why?
|
| Arenaviridae Infections | 1 | 2015 | 53 | 0.490 |
Why?
|
| Microscopy, Video | 7 | 2009 | 242 | 0.490 |
Why?
|
| Th1 Cells | 4 | 2020 | 1037 | 0.490 |
Why?
|
| Monitoring, Immunologic | 1 | 2015 | 98 | 0.490 |
Why?
|
| Neutrophil Infiltration | 8 | 2024 | 387 | 0.480 |
Why?
|
| Chlamydia trachomatis | 2 | 2020 | 239 | 0.480 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 9 | 2010 | 691 | 0.480 |
Why?
|
| Intestines | 8 | 2018 | 1909 | 0.470 |
Why?
|
| Haptens | 3 | 2010 | 163 | 0.470 |
Why?
|
| Fucosyltransferases | 4 | 2003 | 117 | 0.470 |
Why?
|
| Flow Cytometry | 22 | 2022 | 5865 | 0.450 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2006 | 1766 | 0.450 |
Why?
|
| Endothelium, Lymphatic | 4 | 2007 | 63 | 0.450 |
Why?
|
| Lysophospholipids | 6 | 2012 | 337 | 0.450 |
Why?
|
| Antigen-Presenting Cells | 6 | 2022 | 964 | 0.440 |
Why?
|
| Lymph | 3 | 2009 | 77 | 0.430 |
Why?
|
| Yolk Sac | 1 | 2013 | 79 | 0.430 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 7 | 2013 | 267 | 0.430 |
Why?
|
| Signal Transduction | 24 | 2024 | 23397 | 0.420 |
Why?
|
| Bacterial Vaccines | 1 | 2015 | 401 | 0.420 |
Why?
|
| Dermatitis, Contact | 4 | 2013 | 133 | 0.420 |
Why?
|
| Viruses | 3 | 2011 | 376 | 0.410 |
Why?
|
| Rhabdoviridae Infections | 2 | 2010 | 9 | 0.410 |
Why?
|
| Interleukin-23 | 1 | 2014 | 201 | 0.410 |
Why?
|
| Vesicular Stomatitis | 1 | 2012 | 18 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 11 | 2021 | 4369 | 0.400 |
Why?
|
| Mice, Transgenic | 27 | 2020 | 9533 | 0.390 |
Why?
|
| Interferon Type I | 4 | 2021 | 562 | 0.390 |
Why?
|
| Immune Tolerance | 4 | 2017 | 2300 | 0.390 |
Why?
|
| Fetal Stem Cells | 1 | 2011 | 10 | 0.390 |
Why?
|
| E-Selectin | 11 | 2012 | 576 | 0.390 |
Why?
|
| Receptors, CXCR | 2 | 2013 | 52 | 0.390 |
Why?
|
| Peyer's Patches | 5 | 2005 | 119 | 0.380 |
Why?
|
| Uterus | 1 | 2015 | 649 | 0.380 |
Why?
|
| Integrin alpha4 | 4 | 2008 | 87 | 0.360 |
Why?
|
| Thrombopoiesis | 2 | 2012 | 165 | 0.350 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 584 | 0.350 |
Why?
|
| Receptors, Immunologic | 3 | 2013 | 1411 | 0.350 |
Why?
|
| Adult Stem Cells | 2 | 2011 | 221 | 0.340 |
Why?
|
| Sulfotransferases | 3 | 2005 | 149 | 0.340 |
Why?
|
| Vaccination | 3 | 2019 | 3375 | 0.330 |
Why?
|
| Microvilli | 4 | 2001 | 234 | 0.330 |
Why?
|
| Lymphocyte Subsets | 1 | 2010 | 311 | 0.330 |
Why?
|
| Nanoparticles | 6 | 2018 | 1953 | 0.330 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2006 | 555 | 0.330 |
Why?
|
| Platelet Activation | 6 | 2017 | 645 | 0.320 |
Why?
|
| Staining and Labeling | 5 | 2017 | 1083 | 0.320 |
Why?
|
| Microvessels | 1 | 2013 | 574 | 0.310 |
Why?
|
| Selectins | 6 | 2014 | 101 | 0.310 |
Why?
|
| Cytokines | 14 | 2021 | 7377 | 0.310 |
Why?
|
| Monocytes | 6 | 2022 | 2572 | 0.310 |
Why?
|
| Interferon-gamma | 6 | 2020 | 3157 | 0.310 |
Why?
|
| Lymphatic System | 2 | 2007 | 254 | 0.310 |
Why?
|
| Vitamin A | 2 | 2008 | 613 | 0.300 |
Why?
|
| Myeloid Cells | 4 | 2023 | 823 | 0.300 |
Why?
|
| Membrane Glycoproteins | 10 | 2013 | 3701 | 0.300 |
Why?
|
| Antibody-Producing Cells | 1 | 2008 | 140 | 0.300 |
Why?
|
| Gastrointestinal Tract | 3 | 2009 | 831 | 0.290 |
Why?
|
| Leukocyte Rolling | 6 | 2013 | 69 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 9 | 2024 | 1125 | 0.290 |
Why?
|
| Megakaryocytes | 2 | 2012 | 566 | 0.290 |
Why?
|
| Leukotriene B4 | 4 | 2003 | 280 | 0.290 |
Why?
|
| Gene Expression Regulation | 10 | 2024 | 11900 | 0.280 |
Why?
|
| Cell Lineage | 5 | 2013 | 2539 | 0.280 |
Why?
|
| Cells, Cultured | 26 | 2015 | 18955 | 0.280 |
Why?
|
| Stem Cells | 5 | 2018 | 3522 | 0.280 |
Why?
|
| Chemokines, CXC | 7 | 2012 | 422 | 0.280 |
Why?
|
| Clonal Deletion | 1 | 2006 | 74 | 0.270 |
Why?
|
| Toll-Like Receptors | 5 | 2020 | 589 | 0.270 |
Why?
|
| Spleen | 9 | 2016 | 2296 | 0.270 |
Why?
|
| Intestine, Small | 4 | 2014 | 1205 | 0.270 |
Why?
|
| Psoriasis | 2 | 2014 | 937 | 0.270 |
Why?
|
| Immunosuppressive Agents | 6 | 2022 | 4168 | 0.270 |
Why?
|
| Adipose Tissue | 4 | 2022 | 3306 | 0.260 |
Why?
|
| Dinitrofluorobenzene | 2 | 2021 | 17 | 0.260 |
Why?
|
| Microscopy, Fluorescence | 6 | 2014 | 2647 | 0.260 |
Why?
|
| Quantum Dots | 1 | 2007 | 167 | 0.260 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2017 | 1351 | 0.260 |
Why?
|
| Humans | 114 | 2024 | 760437 | 0.260 |
Why?
|
| Receptors, Leukotriene B4 | 2 | 2003 | 92 | 0.260 |
Why?
|
| Capillaries | 3 | 2006 | 755 | 0.260 |
Why?
|
| Stromal Cells | 2 | 2012 | 1330 | 0.250 |
Why?
|
| Central Nervous System | 2 | 2010 | 1337 | 0.250 |
Why?
|
| Antigens, CD | 7 | 2024 | 4000 | 0.250 |
Why?
|
| Blood Vessels | 4 | 2013 | 1113 | 0.250 |
Why?
|
| Chemokine CX3CL1 | 2 | 2023 | 63 | 0.250 |
Why?
|
| Erythroblasts | 2 | 2017 | 142 | 0.240 |
Why?
|
| Vesicular stomatitis Indiana virus | 3 | 2012 | 93 | 0.240 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2010 | 166 | 0.240 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2024 | 254 | 0.240 |
Why?
|
| Self Tolerance | 2 | 2021 | 123 | 0.230 |
Why?
|
| Diphosphonates | 2 | 2023 | 636 | 0.230 |
Why?
|
| Liver | 10 | 2021 | 7531 | 0.230 |
Why?
|
| Autoantigens | 3 | 2021 | 876 | 0.230 |
Why?
|
| Receptors, CCR | 4 | 2009 | 37 | 0.230 |
Why?
|
| Fluorescent Dyes | 5 | 2015 | 1900 | 0.230 |
Why?
|
| Adjuvants, Immunologic | 4 | 2015 | 1035 | 0.220 |
Why?
|
| Digestive System | 1 | 2004 | 244 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2022 | 1841 | 0.220 |
Why?
|
| Membrane Proteins | 10 | 2016 | 7849 | 0.220 |
Why?
|
| Mucous Membrane | 2 | 2018 | 657 | 0.220 |
Why?
|
| Bleomycin | 1 | 2024 | 494 | 0.220 |
Why?
|
| Luminescent Proteins | 6 | 2013 | 836 | 0.220 |
Why?
|
| Fungal Proteins | 1 | 2007 | 910 | 0.220 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2012 | 2531 | 0.220 |
Why?
|
| Peptides | 5 | 2024 | 4338 | 0.210 |
Why?
|
| Disease Models, Animal | 15 | 2024 | 18216 | 0.210 |
Why?
|
| Immunity | 3 | 2024 | 997 | 0.210 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 2014 | 779 | 0.210 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2020 | 140 | 0.210 |
Why?
|
| Vitamins | 2 | 2008 | 1635 | 0.210 |
Why?
|
| Interphase | 1 | 2003 | 228 | 0.210 |
Why?
|
| Interleukin-10 | 3 | 2018 | 1176 | 0.210 |
Why?
|
| Microscopy | 3 | 2004 | 886 | 0.200 |
Why?
|
| Chemokine CXCL1 | 2 | 2021 | 101 | 0.200 |
Why?
|
| Osteopontin | 1 | 2024 | 301 | 0.200 |
Why?
|
| Receptors, IgG | 2 | 2021 | 559 | 0.200 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 367 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 9 | 2023 | 9176 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 5 | 2017 | 2060 | 0.190 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 4 | 2011 | 144 | 0.190 |
Why?
|
| Receptors, CXCR3 | 2 | 2012 | 238 | 0.190 |
Why?
|
| Muromegalovirus | 1 | 2021 | 31 | 0.190 |
Why?
|
| Biological Transport | 3 | 2021 | 2090 | 0.190 |
Why?
|
| Mice, SCID | 4 | 2021 | 2625 | 0.190 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 415 | 0.190 |
Why?
|
| Antibody Formation | 6 | 2014 | 1397 | 0.180 |
Why?
|
| Retinal Neovascularization | 1 | 2024 | 288 | 0.180 |
Why?
|
| Chemokine CXCL2 | 2 | 2018 | 106 | 0.180 |
Why?
|
| Virus Diseases | 2 | 2021 | 719 | 0.180 |
Why?
|
| Benzenesulfonates | 1 | 2021 | 166 | 0.180 |
Why?
|
| Tumor Escape | 1 | 2023 | 370 | 0.180 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 505 | 0.180 |
Why?
|
| Bacteria, Anaerobic | 2 | 2017 | 70 | 0.170 |
Why?
|
| Natural Killer T-Cells | 2 | 2014 | 311 | 0.170 |
Why?
|
| Interleukin-17 | 2 | 2018 | 907 | 0.170 |
Why?
|
| Receptors, Lysosphingolipid | 2 | 2012 | 121 | 0.170 |
Why?
|
| Chemokine CCL22 | 1 | 2019 | 27 | 0.170 |
Why?
|
| Ligands | 11 | 2014 | 3270 | 0.170 |
Why?
|
| Lung Injury | 1 | 2024 | 422 | 0.170 |
Why?
|
| Genitalia | 1 | 2020 | 113 | 0.170 |
Why?
|
| Vaccinia virus | 2 | 2017 | 331 | 0.170 |
Why?
|
| Ghrelin | 1 | 2021 | 252 | 0.160 |
Why?
|
| Urinary Bladder | 2 | 2021 | 1150 | 0.160 |
Why?
|
| Appetite | 1 | 2021 | 247 | 0.160 |
Why?
|
| Somatostatin | 1 | 2021 | 447 | 0.160 |
Why?
|
| Prodrugs | 1 | 2021 | 261 | 0.160 |
Why?
|
| Endothelium | 5 | 2009 | 765 | 0.160 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2018 | 973 | 0.160 |
Why?
|
| Pain | 2 | 2024 | 5075 | 0.160 |
Why?
|
| Mucoproteins | 4 | 2008 | 49 | 0.160 |
Why?
|
| Germinal Center | 3 | 2012 | 380 | 0.150 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2021 | 57 | 0.150 |
Why?
|
| Cell Separation | 2 | 2016 | 1720 | 0.150 |
Why?
|
| Mast Cells | 2 | 2023 | 1391 | 0.150 |
Why?
|
| Immunotherapy | 5 | 2022 | 4649 | 0.150 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 3428 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2018 | 48 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2021 | 822 | 0.150 |
Why?
|
| Glycosphingolipids | 1 | 2018 | 73 | 0.150 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 518 | 0.150 |
Why?
|
| Isoenzymes | 2 | 2007 | 1688 | 0.150 |
Why?
|
| Oligosaccharides | 3 | 2018 | 406 | 0.150 |
Why?
|
| Macrophages, Peritoneal | 4 | 2013 | 236 | 0.150 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2008 | 365 | 0.150 |
Why?
|
| Integrin alpha4beta1 | 3 | 2008 | 119 | 0.150 |
Why?
|
| Tacrolimus | 2 | 2018 | 733 | 0.150 |
Why?
|
| Actins | 3 | 2023 | 2049 | 0.140 |
Why?
|
| Female | 50 | 2024 | 391875 | 0.140 |
Why?
|
| Chemokine CXCL12 | 6 | 2009 | 454 | 0.140 |
Why?
|
| DNA-Binding Proteins | 8 | 2021 | 9598 | 0.140 |
Why?
|
| Vaccinia | 1 | 2017 | 71 | 0.140 |
Why?
|
| Lymphocyte Count | 4 | 2011 | 778 | 0.140 |
Why?
|
| Protein Kinase C | 2 | 2001 | 1202 | 0.140 |
Why?
|
| Polymers | 2 | 2014 | 1615 | 0.140 |
Why?
|
| Microcirculation | 7 | 2010 | 1269 | 0.140 |
Why?
|
| Lymphedema | 1 | 2023 | 525 | 0.140 |
Why?
|
| Sialoglycoproteins | 1 | 1998 | 315 | 0.140 |
Why?
|
| Models, Animal | 2 | 2021 | 2111 | 0.140 |
Why?
|
| Antigens, Neoplasm | 2 | 2022 | 1994 | 0.140 |
Why?
|
| Immunity, Humoral | 3 | 2020 | 604 | 0.140 |
Why?
|
| Microfluidics | 1 | 2022 | 653 | 0.140 |
Why?
|
| Blood-Brain Barrier | 2 | 2021 | 1024 | 0.130 |
Why?
|
| Chemokine CCL21 | 4 | 2007 | 50 | 0.130 |
Why?
|
| Neurons | 1 | 2015 | 9443 | 0.130 |
Why?
|
| Hemostasis | 2 | 2017 | 467 | 0.130 |
Why?
|
| Cell Line | 9 | 2014 | 15598 | 0.130 |
Why?
|
| Ovalbumin | 3 | 2014 | 672 | 0.130 |
Why?
|
| Male | 49 | 2024 | 360035 | 0.130 |
Why?
|
| Drug Delivery Systems | 3 | 2016 | 2224 | 0.130 |
Why?
|
| Chemokine CXCL9 | 2 | 2012 | 135 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 755 | 0.130 |
Why?
|
| Reflex | 1 | 2017 | 376 | 0.130 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2014 | 233 | 0.130 |
Why?
|
| Langerhans Cells | 2 | 2014 | 170 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2018 | 694 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1355 | 0.120 |
Why?
|
| Peptidoglycan | 1 | 2017 | 249 | 0.120 |
Why?
|
| Hemodynamics | 7 | 2002 | 4167 | 0.120 |
Why?
|
| Microglia | 1 | 2024 | 1357 | 0.120 |
Why?
|
| Keratitis, Herpetic | 1 | 2015 | 77 | 0.120 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 95 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2021 | 1567 | 0.120 |
Why?
|
| Neuraminidase | 2 | 2011 | 199 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2009 | 8967 | 0.120 |
Why?
|
| Adrenal Glands | 1 | 2017 | 551 | 0.120 |
Why?
|
| Kidney Cortex | 1 | 2014 | 169 | 0.120 |
Why?
|
| Lipopolysaccharides | 4 | 2017 | 2205 | 0.120 |
Why?
|
| RGS Proteins | 1 | 2014 | 74 | 0.120 |
Why?
|
| Vaccines, Inactivated | 1 | 2015 | 179 | 0.120 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2014 | 431 | 0.120 |
Why?
|
| Fetus | 2 | 2012 | 1863 | 0.120 |
Why?
|
| Peritonitis | 4 | 2015 | 369 | 0.120 |
Why?
|
| Vitamin D | 1 | 2008 | 3303 | 0.120 |
Why?
|
| Chemotactic Factors | 2 | 2008 | 197 | 0.120 |
Why?
|
| Kinetics | 4 | 2008 | 6377 | 0.120 |
Why?
|
| Mesenteric Veins | 1 | 1994 | 86 | 0.120 |
Why?
|
| Cell Division | 6 | 2007 | 4461 | 0.120 |
Why?
|
| Interleukin-1 | 3 | 1994 | 1250 | 0.120 |
Why?
|
| Wound Healing | 2 | 2024 | 2799 | 0.120 |
Why?
|
| Organ Specificity | 4 | 2017 | 1956 | 0.120 |
Why?
|
| Pituitary-Adrenal System | 1 | 2017 | 549 | 0.120 |
Why?
|
| Aminoquinolines | 1 | 2014 | 107 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2018 | 706 | 0.110 |
Why?
|
| Bacteroides fragilis | 1 | 2015 | 252 | 0.110 |
Why?
|
| Interleukin-2 | 4 | 2014 | 1891 | 0.110 |
Why?
|
| Diagnostic Imaging | 2 | 2006 | 3541 | 0.110 |
Why?
|
| Aging | 2 | 2024 | 8689 | 0.110 |
Why?
|
| Axotomy | 1 | 2013 | 71 | 0.110 |
Why?
|
| Thermogenesis | 1 | 2018 | 473 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13616 | 0.110 |
Why?
|
| Immunologic Techniques | 3 | 2011 | 213 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2017 | 698 | 0.110 |
Why?
|
| Neoplasms | 8 | 2022 | 22083 | 0.110 |
Why?
|
| Action Potentials | 1 | 2020 | 1830 | 0.110 |
Why?
|
| Immunoglobulins | 3 | 2008 | 859 | 0.110 |
Why?
|
| Dextrans | 1 | 2015 | 573 | 0.110 |
Why?
|
| Metalloendopeptidases | 3 | 2004 | 393 | 0.110 |
Why?
|
| Neutropenia | 2 | 2017 | 884 | 0.110 |
Why?
|
| Veins | 1 | 2017 | 767 | 0.100 |
Why?
|
| Kupffer Cells | 2 | 2011 | 143 | 0.100 |
Why?
|
| Lung | 4 | 2024 | 9973 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2021 | 586 | 0.100 |
Why?
|
| Lymphotoxin alpha1, beta2 Heterotrimer | 1 | 2012 | 3 | 0.100 |
Why?
|
| Interleukins | 2 | 2014 | 782 | 0.100 |
Why?
|
| Antigens, Viral | 3 | 2001 | 987 | 0.100 |
Why?
|
| Receptors, CCR7 | 5 | 2007 | 107 | 0.100 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 242 | 0.100 |
Why?
|
| Lymphocyte Cooperation | 1 | 2012 | 113 | 0.100 |
Why?
|
| Refrigeration | 1 | 2011 | 27 | 0.100 |
Why?
|
| Viral Vaccines | 1 | 2017 | 596 | 0.100 |
Why?
|
| Cancer Vaccines | 1 | 2019 | 1050 | 0.100 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1991 | 52 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2014 | 592 | 0.100 |
Why?
|
| Trigeminal Nerve | 1 | 2013 | 248 | 0.100 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 1272 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 502 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2011 | 61 | 0.100 |
Why?
|
| Angiotensin II | 1 | 2014 | 848 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 1689 | 0.090 |
Why?
|
| Skull | 3 | 2002 | 818 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 2 | 2021 | 513 | 0.090 |
Why?
|
| Vaccines, Synthetic | 1 | 2014 | 619 | 0.090 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2015 | 540 | 0.090 |
Why?
|
| Calcium | 3 | 2023 | 5726 | 0.090 |
Why?
|
| Models, Biological | 9 | 2022 | 9462 | 0.090 |
Why?
|
| Antibodies | 3 | 2016 | 2421 | 0.090 |
Why?
|
| Vesicular stomatitis New Jersey virus | 1 | 2010 | 1 | 0.090 |
Why?
|
| Interleukin-12 | 1 | 2013 | 583 | 0.090 |
Why?
|
| Endosomes | 1 | 2013 | 520 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 961 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2003 | 2247 | 0.090 |
Why?
|
| Multiple Sclerosis | 2 | 2021 | 3220 | 0.090 |
Why?
|
| Interleukin-15 | 2 | 2001 | 185 | 0.090 |
Why?
|
| Distamycins | 1 | 2010 | 10 | 0.090 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2017 | 221 | 0.090 |
Why?
|
| Transfection | 6 | 2007 | 5776 | 0.090 |
Why?
|
| Oxazolone | 3 | 2006 | 61 | 0.090 |
Why?
|
| Dermatitis, Atopic | 1 | 2018 | 716 | 0.090 |
Why?
|
| Graft Survival | 2 | 2018 | 3806 | 0.090 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2015 | 435 | 0.090 |
Why?
|
| Phagocytosis | 5 | 2016 | 1536 | 0.090 |
Why?
|
| Protein Conformation | 4 | 2008 | 3969 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 345 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 697 | 0.090 |
Why?
|
| Mice, Mutant Strains | 6 | 2010 | 1751 | 0.090 |
Why?
|
| Cell Tracking | 1 | 2011 | 138 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 1079 | 0.090 |
Why?
|
| Protein Binding | 7 | 2012 | 9340 | 0.090 |
Why?
|
| Simian immunodeficiency virus | 1 | 2015 | 808 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2003 | 2278 | 0.090 |
Why?
|
| HMGA1a Protein | 1 | 2010 | 61 | 0.090 |
Why?
|
| Microscopy, Confocal | 4 | 2017 | 1967 | 0.090 |
Why?
|
| Trigeminal Ganglion | 1 | 2011 | 190 | 0.090 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2010 | 112 | 0.090 |
Why?
|
| Conjunctiva | 1 | 2013 | 479 | 0.080 |
Why?
|
| Influenza A virus | 2 | 2024 | 457 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 3 | 2006 | 2693 | 0.080 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 924 | 0.080 |
Why?
|
| Heparitin Sulfate | 1 | 2010 | 223 | 0.080 |
Why?
|
| Intercellular Junctions | 2 | 2021 | 195 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 2 | 2015 | 753 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2007 | 3734 | 0.080 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2006 | 562 | 0.080 |
Why?
|
| Epithelial Cells | 4 | 2024 | 3661 | 0.080 |
Why?
|
| Sirolimus | 2 | 2014 | 1533 | 0.080 |
Why?
|
| Immunophenotyping | 3 | 2022 | 1870 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 5 | 2003 | 6128 | 0.080 |
Why?
|
| Interleukin-6 | 3 | 2013 | 3209 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2010 | 1355 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 920 | 0.080 |
Why?
|
| Injections | 2 | 2010 | 829 | 0.080 |
Why?
|
| Embryonic Development | 2 | 2011 | 717 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3874 | 0.080 |
Why?
|
| Thrombocytopenia | 2 | 2017 | 1174 | 0.080 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 685 | 0.080 |
Why?
|
| HIV | 2 | 2015 | 1582 | 0.080 |
Why?
|
| Allosteric Regulation | 2 | 2007 | 426 | 0.080 |
Why?
|
| Paralysis | 1 | 2010 | 250 | 0.080 |
Why?
|
| Endotoxemia | 1 | 2010 | 196 | 0.080 |
Why?
|
| Blood Cells | 3 | 2002 | 305 | 0.080 |
Why?
|
| Rabbits | 5 | 1997 | 4780 | 0.080 |
Why?
|
| Coculture Techniques | 3 | 2013 | 1340 | 0.080 |
Why?
|
| Time Factors | 11 | 2013 | 39947 | 0.080 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1089 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2024 | 12121 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 367 | 0.080 |
Why?
|
| Glycosylation | 4 | 2020 | 1097 | 0.080 |
Why?
|
| Thrombosis | 3 | 2017 | 2940 | 0.080 |
Why?
|
| Vibrio cholerae | 1 | 2014 | 793 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 2001 | 818 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 2 | 2008 | 927 | 0.080 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 600 | 0.080 |
Why?
|
| Hepatic Stellate Cells | 1 | 2009 | 119 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 1023 | 0.070 |
Why?
|
| Virus Latency | 1 | 2011 | 363 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2006 | 2911 | 0.070 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2007 | 51 | 0.070 |
Why?
|
| Blood Physiological Phenomena | 1 | 2007 | 53 | 0.070 |
Why?
|
| Eye Diseases | 1 | 2013 | 655 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 3792 | 0.070 |
Why?
|
| Dinucleoside Phosphates | 1 | 2007 | 72 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2017 | 2049 | 0.070 |
Why?
|
| Macrophage-1 Antigen | 3 | 2003 | 286 | 0.070 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2007 | 63 | 0.070 |
Why?
|
| Thoracic Duct | 1 | 2007 | 64 | 0.070 |
Why?
|
| Heart Transplantation | 2 | 2018 | 3233 | 0.070 |
Why?
|
| Cell Proliferation | 5 | 2021 | 10425 | 0.070 |
Why?
|
| RNA Interference | 2 | 2014 | 2832 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 1807 | 0.070 |
Why?
|
| Herpes Simplex | 1 | 2011 | 478 | 0.070 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2007 | 99 | 0.070 |
Why?
|
| Cofilin 1 | 1 | 2007 | 15 | 0.070 |
Why?
|
| Polysaccharides | 2 | 2020 | 1014 | 0.070 |
Why?
|
| Platelet Transfusion | 3 | 2017 | 297 | 0.070 |
Why?
|
| Nitrophenols | 1 | 2007 | 169 | 0.070 |
Why?
|
| Shear Strength | 1 | 2007 | 160 | 0.070 |
Why?
|
| Hagfishes | 1 | 2006 | 12 | 0.070 |
Why?
|
| Lymphatic Vessels | 2 | 2016 | 358 | 0.070 |
Why?
|
| Mesentery | 2 | 2021 | 202 | 0.070 |
Why?
|
| Apoptosis | 6 | 2011 | 9468 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2016 | 1588 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 2008 | 467 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2007 | 942 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2006 | 34 | 0.070 |
Why?
|
| Immunization | 3 | 2022 | 1226 | 0.070 |
Why?
|
| Peripheral Nerves | 1 | 2010 | 479 | 0.070 |
Why?
|
| Caspases | 2 | 2007 | 876 | 0.070 |
Why?
|
| Vitamin A Deficiency | 1 | 2006 | 88 | 0.070 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 2014 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2007 | 727 | 0.070 |
Why?
|
| Fetal Blood | 1 | 2013 | 1346 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2011 | 1232 | 0.070 |
Why?
|
| Interleukin-5 | 1 | 2006 | 269 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 400 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 1341 | 0.060 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2007 | 569 | 0.060 |
Why?
|
| Mice, Congenic | 1 | 2005 | 97 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1347 | 0.060 |
Why?
|
| Leukocyte Count | 4 | 2015 | 1596 | 0.060 |
Why?
|
| Mammals | 2 | 2023 | 1132 | 0.060 |
Why?
|
| Hepatitis B | 1 | 2011 | 706 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 2014 | 5105 | 0.060 |
Why?
|
| Collagen | 3 | 2009 | 2637 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 1674 | 0.060 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2008 | 577 | 0.060 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2006 | 305 | 0.060 |
Why?
|
| Receptors, Nicotinic | 1 | 2008 | 495 | 0.060 |
Why?
|
| Arterioles | 2 | 2014 | 250 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2008 | 1164 | 0.060 |
Why?
|
| Phenotype | 2 | 2022 | 16585 | 0.060 |
Why?
|
| Transcellular Cell Migration | 1 | 2024 | 3 | 0.060 |
Why?
|
| Transplantation, Homologous | 4 | 2019 | 4808 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 94 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 1409 | 0.060 |
Why?
|
| Integrin alpha1 | 1 | 2004 | 13 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4567 | 0.060 |
Why?
|
| Complement C1q | 1 | 2004 | 94 | 0.060 |
Why?
|
| Cell Membrane | 3 | 2011 | 3685 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2017 | 2468 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2008 | 560 | 0.060 |
Why?
|
| Stress, Mechanical | 3 | 2010 | 1674 | 0.060 |
Why?
|
| Nanotechnology | 1 | 2010 | 712 | 0.060 |
Why?
|
| Antigens, Differentiation | 2 | 2011 | 910 | 0.060 |
Why?
|
| Cold Temperature | 2 | 2003 | 786 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2007 | 471 | 0.060 |
Why?
|
| Protein Engineering | 1 | 2007 | 547 | 0.060 |
Why?
|
| Endocytosis | 2 | 2021 | 958 | 0.060 |
Why?
|
| Melanoma, Experimental | 2 | 2018 | 559 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2006 | 545 | 0.060 |
Why?
|
| Receptor, trkB | 1 | 2024 | 124 | 0.060 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 291 | 0.060 |
Why?
|
| Omentum | 1 | 2024 | 168 | 0.050 |
Why?
|
| Dipeptides | 2 | 2004 | 391 | 0.050 |
Why?
|
| Immunohistochemistry | 5 | 2014 | 11070 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 1114 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2007 | 1792 | 0.050 |
Why?
|
| Ear | 2 | 2002 | 172 | 0.050 |
Why?
|
| Chymotrypsin | 2 | 1993 | 138 | 0.050 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2413 | 0.050 |
Why?
|
| Fibrosis | 2 | 2023 | 2048 | 0.050 |
Why?
|
| Eosinophils | 2 | 2000 | 947 | 0.050 |
Why?
|
| Air | 1 | 2003 | 186 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 2 | 2024 | 2642 | 0.050 |
Why?
|
| Hydroxamic Acids | 2 | 2004 | 481 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 1337 | 0.050 |
Why?
|
| Melanoma | 2 | 2016 | 5704 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2009 | 1959 | 0.050 |
Why?
|
| Lasers | 2 | 2007 | 951 | 0.050 |
Why?
|
| Muscle, Skeletal | 4 | 2009 | 4923 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 1942 | 0.050 |
Why?
|
| Trifluoperazine | 1 | 2001 | 37 | 0.050 |
Why?
|
| Capillary Leak Syndrome | 1 | 2002 | 34 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2007 | 738 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 3076 | 0.050 |
Why?
|
| Freund's Adjuvant | 1 | 2001 | 148 | 0.050 |
Why?
|
| Splanchnic Circulation | 2 | 1992 | 114 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 678 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 1134 | 0.050 |
Why?
|
| Computational Biology | 2 | 2014 | 3510 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2006 | 1228 | 0.050 |
Why?
|
| Lipoproteins, LDL | 2 | 1995 | 642 | 0.050 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 9410 | 0.050 |
Why?
|
| Thrombospondins | 1 | 2002 | 193 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2007 | 3603 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2010 | 2199 | 0.050 |
Why?
|
| Thrombomodulin | 1 | 2001 | 105 | 0.050 |
Why?
|
| Chemokine CCL19 | 3 | 2007 | 35 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2023 | 483 | 0.050 |
Why?
|
| Calmodulin | 1 | 2001 | 218 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1161 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2003 | 317 | 0.050 |
Why?
|
| Blood Circulation | 1 | 2001 | 249 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 1115 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 3155 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 599 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 882 | 0.040 |
Why?
|
| Pregnancy | 2 | 2013 | 29831 | 0.040 |
Why?
|
| Heparin | 1 | 2007 | 1633 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 1850 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5359 | 0.040 |
Why?
|
| Anti-Retroviral Agents | 1 | 2010 | 1781 | 0.040 |
Why?
|
| Immunity, Cellular | 2 | 2014 | 1559 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2003 | 532 | 0.040 |
Why?
|
| Insulin | 1 | 2014 | 6591 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 794 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 870 | 0.040 |
Why?
|
| Fluorescence | 2 | 2017 | 756 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2004 | 633 | 0.040 |
Why?
|
| Mesoderm | 1 | 2003 | 673 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2021 | 306 | 0.040 |
Why?
|
| Cadherins | 1 | 2024 | 904 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2005 | 1054 | 0.040 |
Why?
|
| DNA Primers | 1 | 2003 | 2820 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 215 | 0.040 |
Why?
|
| Cell Line, Tumor | 5 | 2019 | 16945 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 2895 | 0.040 |
Why?
|
| Receptors, CCR4 | 1 | 2019 | 77 | 0.040 |
Why?
|
| Disulfides | 1 | 2001 | 465 | 0.040 |
Why?
|
| Fever | 1 | 2006 | 1618 | 0.040 |
Why?
|
| Bacterial Proteins | 2 | 2014 | 3842 | 0.040 |
Why?
|
| Rhodamine 123 | 1 | 1998 | 37 | 0.040 |
Why?
|
| Reactive Oxygen Species | 3 | 2021 | 2137 | 0.040 |
Why?
|
| Gene Expression | 3 | 2013 | 7582 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5778 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 54339 | 0.040 |
Why?
|
| Arteries | 2 | 2013 | 1125 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 347 | 0.040 |
Why?
|
| Binding Sites | 1 | 2007 | 6042 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2022 | 1667 | 0.040 |
Why?
|
| Salmonella enterica | 1 | 2018 | 75 | 0.040 |
Why?
|
| Bacteremia | 1 | 2005 | 979 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2018 | 9 | 0.040 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2018 | 12 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 828 | 0.040 |
Why?
|
| Mice, Inbred AKR | 1 | 1998 | 104 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7208 | 0.040 |
Why?
|
| Transcytosis | 1 | 2018 | 45 | 0.040 |
Why?
|
| Leukemia | 1 | 2006 | 1522 | 0.040 |
Why?
|
| G(M1) Ganglioside | 1 | 2018 | 87 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2004 | 17639 | 0.040 |
Why?
|
| Rhodamines | 1 | 1998 | 178 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 328 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1598 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2001 | 637 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 2 | 2014 | 490 | 0.040 |
Why?
|
| HIV-1 | 1 | 2015 | 6859 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2009 | 2560 | 0.040 |
Why?
|
| Immunoglobulin G | 4 | 2013 | 4549 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 2018 | 168 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2009 | 2803 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2014 | 1647 | 0.040 |
Why?
|
| Survival Rate | 2 | 2010 | 12698 | 0.040 |
Why?
|
| Receptors, Thromboxane | 1 | 1997 | 30 | 0.040 |
Why?
|
| Solutions | 1 | 2018 | 411 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 1454 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2007 | 5427 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4277 | 0.040 |
Why?
|
| Protein Folding | 1 | 2001 | 867 | 0.040 |
Why?
|
| ADAM Proteins | 2 | 2011 | 237 | 0.030 |
Why?
|
| Ceramides | 1 | 2018 | 200 | 0.030 |
Why?
|
| Click Chemistry | 1 | 2017 | 95 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2016 | 1886 | 0.030 |
Why?
|
| Platelet Adhesiveness | 1 | 2017 | 154 | 0.030 |
Why?
|
| HIV Infections | 3 | 2015 | 17328 | 0.030 |
Why?
|
| Cornea | 2 | 2015 | 1331 | 0.030 |
Why?
|
| Cell Survival | 3 | 2018 | 5790 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2017 | 26280 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 80430 | 0.030 |
Why?
|
| Base Sequence | 2 | 2007 | 12449 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2008 | 4903 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 5815 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 3 | 2007 | 221 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 2419 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2011 | 12785 | 0.030 |
Why?
|
| Epitopes | 2 | 2005 | 2504 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 344 | 0.030 |
Why?
|
| Gestational Age | 2 | 2017 | 3574 | 0.030 |
Why?
|
| Receptors, NK Cell Lectin-Like | 1 | 2015 | 30 | 0.030 |
Why?
|
| Proteins | 2 | 2014 | 6033 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 2 | 2007 | 68 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2018 | 3075 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2018 | 363 | 0.030 |
Why?
|
| Mutation | 6 | 2011 | 30025 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 2017 | 346 | 0.030 |
Why?
|
| Angiotensin II Type 2 Receptor Blockers | 1 | 2014 | 7 | 0.030 |
Why?
|
| Infant, Premature | 2 | 2017 | 2104 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 712 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 219 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2018 | 4355 | 0.030 |
Why?
|
| Protein Transport | 2 | 2013 | 1965 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2014 | 60 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1994 | 74 | 0.030 |
Why?
|
| Iliac Artery | 1 | 1996 | 343 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3796 | 0.030 |
Why?
|
| Constriction | 1 | 1994 | 171 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 1995 | 115 | 0.030 |
Why?
|
| Symbiosis | 1 | 2017 | 294 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 12918 | 0.030 |
Why?
|
| Denervation | 1 | 2015 | 263 | 0.030 |
Why?
|
| Glycocalyx | 1 | 2015 | 95 | 0.030 |
Why?
|
| Rheology | 1 | 1995 | 348 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2017 | 406 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 151 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 1445 | 0.030 |
Why?
|
| Polyesters | 1 | 2016 | 374 | 0.030 |
Why?
|
| Renal Circulation | 1 | 2014 | 291 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2001 | 1803 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 215 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 13445 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 384 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6230 | 0.030 |
Why?
|
| von Willebrand Factor | 2 | 2011 | 673 | 0.030 |
Why?
|
| Nanocapsules | 1 | 2014 | 92 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2001 | 2207 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 1571 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1994 | 284 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 2013 | 114 | 0.030 |
Why?
|
| Dermis | 2 | 2006 | 202 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 950 | 0.030 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2014 | 98 | 0.030 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 405 | 0.030 |
Why?
|
| Aorta | 2 | 2014 | 2042 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 3710 | 0.030 |
Why?
|
| Monte Carlo Method | 2 | 2009 | 1257 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 3839 | 0.030 |
Why?
|
| Hematocrit | 1 | 1994 | 625 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 1753 | 0.030 |
Why?
|
| Triglycerides | 1 | 2021 | 2458 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5663 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2024 | 1517 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 595 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1993 | 411 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 787 | 0.030 |
Why?
|
| Platelet Aggregation | 2 | 2008 | 773 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2014 | 289 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2013 | 436 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 787 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 194 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2012 | 67 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 177 | 0.030 |
Why?
|
| Acute Disease | 1 | 2003 | 7230 | 0.030 |
Why?
|
| Gangliosides | 1 | 1993 | 132 | 0.030 |
Why?
|
| Factor VIII | 1 | 2014 | 349 | 0.030 |
Why?
|
| Retroviridae | 2 | 2006 | 850 | 0.030 |
Why?
|
| Organoids | 1 | 2018 | 741 | 0.030 |
Why?
|
| Giant Cells | 1 | 2012 | 188 | 0.020 |
Why?
|
| Kidney | 1 | 2007 | 7046 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2012 | 92 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1998 | 1420 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2014 | 8311 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2002 | 2566 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 5794 | 0.020 |
Why?
|
| HMGB Proteins | 1 | 2011 | 45 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2012 | 180 | 0.020 |
Why?
|
| Clodronic Acid | 1 | 2011 | 59 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2012 | 316 | 0.020 |
Why?
|
| Hemophilia A | 1 | 2014 | 360 | 0.020 |
Why?
|
| Antigens, CD1d | 1 | 2012 | 217 | 0.020 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2011 | 104 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2011 | 123 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4509 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2011 | 168 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 451 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1248 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2003 | 1922 | 0.020 |
Why?
|
| Cricetinae | 4 | 1997 | 2427 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2014 | 512 | 0.020 |
Why?
|
| AT Rich Sequence | 1 | 2010 | 10 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 696 | 0.020 |
Why?
|
| Virulence | 1 | 2014 | 1301 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2011 | 141 | 0.020 |
Why?
|
| Oxygen | 1 | 2002 | 4222 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2006 | 838 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2012 | 563 | 0.020 |
Why?
|
| Blood Cell Count | 2 | 2004 | 397 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2011 | 3592 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 2012 | 532 | 0.020 |
Why?
|
| Blood Donors | 1 | 2012 | 345 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1991 | 445 | 0.020 |
Why?
|
| Capillary Permeability | 2 | 2004 | 773 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2011 | 1155 | 0.020 |
Why?
|
| Mesocricetus | 3 | 1995 | 252 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2014 | 1134 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10759 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2018 | 2906 | 0.020 |
Why?
|
| Thioglycolates | 2 | 2000 | 38 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2676 | 0.020 |
Why?
|
| Chemokine CXCL13 | 1 | 2009 | 59 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 1225 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 2015 | 896 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2015 | 2322 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1995 | 940 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2011 | 476 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 1481 | 0.020 |
Why?
|
| Glutamates | 1 | 1990 | 389 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2013 | 523 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 614 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1610 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 1492 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 1824 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 932 | 0.020 |
Why?
|
| Interferons | 1 | 2011 | 704 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 1974 | 0.020 |
Why?
|
| Imidazoles | 1 | 2014 | 1179 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 2228 | 0.020 |
Why?
|
| Succinimides | 1 | 2007 | 81 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2009 | 215 | 0.020 |
Why?
|
| Perfusion | 1 | 1992 | 1374 | 0.020 |
Why?
|
| Endotoxins | 1 | 2010 | 521 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 528 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2003 | 3759 | 0.020 |
Why?
|
| Adult | 5 | 2017 | 220781 | 0.020 |
Why?
|
| Virus Replication | 1 | 2015 | 2435 | 0.020 |
Why?
|
| Liposomes | 1 | 2011 | 781 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2011 | 640 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2009 | 4116 | 0.020 |
Why?
|
| Homeodomain Proteins | 2 | 2007 | 2413 | 0.020 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2009 | 305 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2007 | 31 | 0.020 |
Why?
|
| Breeding | 1 | 2006 | 51 | 0.020 |
Why?
|
| Nanomedicine | 1 | 2010 | 291 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2009 | 177 | 0.020 |
Why?
|
| Sepsis | 2 | 2001 | 2583 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2852 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3800 | 0.020 |
Why?
|
| Biophysics | 1 | 2008 | 380 | 0.020 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2007 | 43 | 0.020 |
Why?
|
| Syndrome | 1 | 1993 | 3267 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 188 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2188 | 0.020 |
Why?
|
| Orthomyxoviridae | 1 | 2007 | 147 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2805 | 0.020 |
Why?
|
| Endopeptidases | 2 | 2003 | 772 | 0.020 |
Why?
|
| Bacteria | 1 | 2017 | 2217 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2007 | 462 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20078 | 0.020 |
Why?
|
| Gadolinium | 1 | 2011 | 960 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 370 | 0.020 |
Why?
|
| Immunoglobulin D | 1 | 2005 | 57 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3587 | 0.020 |
Why?
|
| Receptors, Complement 3d | 1 | 2005 | 117 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 1459 | 0.020 |
Why?
|
| Brain Edema | 1 | 1990 | 604 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2104 | 0.020 |
Why?
|
| Talin | 1 | 2005 | 46 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2006 | 293 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2453 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 576 | 0.020 |
Why?
|
| Thymoma | 1 | 2006 | 187 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 5031 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2009 | 6230 | 0.020 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2004 | 22 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6525 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 931 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 417 | 0.020 |
Why?
|
| Premature Birth | 1 | 2017 | 1780 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 1205 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2004 | 216 | 0.010 |
Why?
|
| Lectins | 1 | 2006 | 491 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2005 | 160 | 0.010 |
Why?
|
| Cattle | 1 | 2010 | 3849 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 2004 | 176 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 1745 | 0.010 |
Why?
|
| Acetylglucosamine | 1 | 2005 | 189 | 0.010 |
Why?
|
| Plasma Cells | 1 | 2007 | 599 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2058 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2011 | 795 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 1999 | 4518 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9267 | 0.010 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2004 | 113 | 0.010 |
Why?
|
| Cytidine Deaminase | 1 | 2005 | 245 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2018 | 6380 | 0.010 |
Why?
|
| Germ Cells | 1 | 2007 | 634 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2007 | 1233 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 422 | 0.010 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2003 | 14 | 0.010 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 150 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 1091 | 0.010 |
Why?
|
| Communicable Disease Control | 1 | 2010 | 848 | 0.010 |
Why?
|
| T-Box Domain Proteins | 1 | 2006 | 468 | 0.010 |
Why?
|
| Amoeba | 1 | 2003 | 20 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 2004 | 231 | 0.010 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2003 | 60 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 2002 | 62 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1995 | 944 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1528 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 545 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2444 | 0.010 |
Why?
|
| Cell Count | 1 | 2006 | 1834 | 0.010 |
Why?
|
| Drug Design | 1 | 2007 | 1050 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 2003 | 128 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 740 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 336 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 1874 | 0.010 |
Why?
|
| Epithelium | 1 | 2006 | 1603 | 0.010 |
Why?
|
| Thrombin | 1 | 2004 | 590 | 0.010 |
Why?
|
| Listeriosis | 1 | 2003 | 150 | 0.010 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2001 | 50 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1725 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2017 | 7948 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1649 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2485 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2006 | 2113 | 0.010 |
Why?
|
| Morpholines | 1 | 2004 | 580 | 0.010 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2001 | 73 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9309 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2003 | 250 | 0.010 |
Why?
|
| Cell Size | 1 | 2003 | 624 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 1009 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2006 | 1073 | 0.010 |
Why?
|
| Palatine Tonsil | 1 | 2001 | 193 | 0.010 |
Why?
|
| Ligation | 1 | 2001 | 448 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 1530 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 901 | 0.010 |
Why?
|
| Antigens, CD19 | 1 | 2003 | 425 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 621 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 754 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1094 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2005 | 1167 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2009 | 2133 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2003 | 621 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2004 | 719 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 2001 | 378 | 0.010 |
Why?
|
| K562 Cells | 1 | 2001 | 642 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13338 | 0.010 |
Why?
|
| Indoles | 1 | 2007 | 1833 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3777 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2006 | 1400 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 753 | 0.010 |
Why?
|
| Cesium Radioisotopes | 1 | 1998 | 38 | 0.010 |
Why?
|
| Aged | 3 | 2017 | 168840 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 1999 | 79 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1994 | 8479 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3510 | 0.010 |
Why?
|
| Fibrin | 1 | 2001 | 505 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2007 | 2929 | 0.010 |
Why?
|
| Hemorheology | 1 | 1999 | 144 | 0.010 |
Why?
|
| Chlorides | 1 | 2001 | 665 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1998 | 352 | 0.010 |
Why?
|
| Ear, External | 1 | 1999 | 164 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3765 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 1135 | 0.010 |
Why?
|
| Rats | 2 | 2011 | 23712 | 0.010 |
Why?
|
| Brain Injuries | 1 | 1990 | 2049 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4063 | 0.010 |
Why?
|
| Edema | 1 | 2002 | 769 | 0.010 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1997 | 58 | 0.010 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1997 | 65 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 751 | 0.010 |
Why?
|
| Middle Aged | 3 | 2017 | 220382 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 1363 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 2860 | 0.010 |
Why?
|
| Thromboxane A2 | 1 | 1997 | 88 | 0.010 |
Why?
|
| Calcimycin | 1 | 1997 | 213 | 0.010 |
Why?
|
| Splenectomy | 1 | 1998 | 391 | 0.010 |
Why?
|
| Opsonin Proteins | 1 | 1996 | 147 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1996 | 110 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1997 | 198 | 0.010 |
Why?
|
| Differential Threshold | 1 | 1996 | 80 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1759 | 0.010 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1996 | 173 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2007 | 3414 | 0.010 |
Why?
|
| Muscles | 1 | 2000 | 1575 | 0.010 |
Why?
|
| 1-Butanol | 1 | 1995 | 13 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2001 | 1154 | 0.010 |
Why?
|
| Butanols | 1 | 1995 | 19 | 0.010 |
Why?
|
| Leukocytosis | 1 | 1996 | 251 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1995 | 53 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1995 | 143 | 0.010 |
Why?
|
| Child | 1 | 2003 | 80086 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 483 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5662 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1995 | 140 | 0.010 |
Why?
|
| Videotape Recording | 1 | 1996 | 337 | 0.010 |
Why?
|
| CHO Cells | 1 | 1997 | 1389 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7597 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3392 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 686 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 1693 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 2721 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 4391 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4630 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3446 | 0.010 |
Why?
|
| Cheek | 1 | 1991 | 65 | 0.010 |
Why?
|
| Mitochondria | 1 | 2003 | 3624 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 2821 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1992 | 42209 | 0.010 |
Why?
|
| Permeability | 1 | 1991 | 721 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 1991 | 430 | 0.000 |
Why?
|
| Survival Analysis | 1 | 2001 | 10075 | 0.000 |
Why?
|
| Body Water | 1 | 1990 | 340 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2090 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1991 | 675 | 0.000 |
Why?
|
| Algorithms | 1 | 2008 | 14002 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1990 | 959 | 0.000 |
Why?
|
| Survivors | 1 | 1997 | 2369 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2217 | 0.000 |
Why?
|
| Organ Size | 1 | 1990 | 2252 | 0.000 |
Why?
|
| Sodium | 1 | 1990 | 1589 | 0.000 |
Why?
|
| Glutamic Acid | 1 | 1990 | 1175 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2006 | 41366 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1999 | 8519 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 17854 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 15820 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1997 | 58859 | 0.000 |
Why?
|
| Brain | 1 | 1990 | 27060 | 0.000 |
Why?
|